Hypercomplementaemia as a marker of the evolution from benign to malignant B cell proliferation in patients with type II mixed cryoglobulinaemia
Vitali, C.; Ferri, C.; Nasti, P.; La Civita, L.; Mazzantini, M.; Longombardo, G.; Bombardieri, S.
British Journal of Rheumatology 33(8): 791-792
1994
ISSN/ISBN: 0263-7103 PMID: 8055216 Document Number: 428650
Document emailed within 1 workday
Related Documents
Szczepulska-Wójcik, E.; Langfort, R.; Roszkowski-Sliz, K. 2007: A comparative evaluation of immunohistochemical markers for the differential diagnosis between malignant mesothelioma, non-small cell carcinoma involving the pleura, and benign reactive mesothelial cell proliferation Pneumonologia i Alergologia Polska 75(1): 57-69Kamei, I.; Yoshida, N.; Yukawa, S.; Yabumoto, M.; Iwamoto, M.; Kuriyama, T.; Yokoyama, M.; Shizuki, K. 1992: Malignant transformation of benign mixed tumor of lacrimal gland to squamous cell carcinoma 19 years after initial surgery: report of a case No Shinkei Geka. Neurological Surgery 20(1): 79-83
Pinto de Moraes, H.; Herrera, G.A.; Mendonca, A.M.; Estrela, R.R. 1986: Metastatic malignant mixed tumor of the skin. Ultrastructural and immunocytochemical characterization, histogenetic considerations and comparison with benign mixed tumors of skin and salivary glands Applied Pathology 4(3): 199-208
Cerwenka, H.; Aigner, R.; Bacher, H.; Werkgartner, G.; el-Shabrawi, A.; Quehenberger, F.; Mischinger, H.J. 1999: TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions Anticancer Research 19(1b): 849-851
Menegatti, E.; Messina, M.; Oddone, V.; Rubini, E.; Sciascia, S.; Naretto, C.; Baldovino, S.; Roccatello, D. 2016: Immunogenetics of complement in mixed cryoglobulinaemia Clinical and Experimental Rheumatology 34(3 Suppl. 97): S12-S15
Vitolo, B.; Lidonnici, M.R.; Montecucco, C.; Montecucco, A. 2005: A new monoclonal antibody against DNA ligase I is a suitable marker of cell proliferation in cultured cell and tissue section samples European Journal of Histochemistry: Ejh 49(4): 349-354
Puissant, A.; Rouffy, J.; Pestel, M.; Duperrat, B. 1973: Lymphomatoid papulosis. a histologically malignant disease, with benign evolution Annales de Medecine Interne 124(12): 909-914
Garcia-Bragado, F.; Vilardell, M.; Fonollosa, V.; Ruibal, A.; Gallart, T.; Cuxart, A. 1981: Essential mixed cryoglobulinaemia and hepatitis B virus La Nouvelle Presse Medicale 10(36): 2955-2957
Shoenfeld, Y.; Pick, A.I.; Gura, V.; Frohlichman, R.; Pinkhas, J. 1978: Systemic lupus erythematosus associated with mixed cryoglobulinaemia and circulating anticoagulant South African Medical Journal 54(25): 1056-1058
Antonić, J.; Rakar, S. 1996: Validity of colour and pulsed Doppler US and tumour marker CA 125 in differentiation between benign and malignant ovarian masses European Journal of Gynaecological Oncology 17(1): 29-35
Montero, J.M.; Argueta, A.E.; Dollete, R.E.; Irish, T.J.; King, J.N. 1974: Parotid benign giant mixed tumor of forty-two years duration with malignant transformation Virginia Medical Monthly 101(1): 39-42
Accolla, R.S.; Moretta, A.; Cerottini, J.C. 1981: Allogeneic mixed lymphocyte reactions in humans: pretreatment of either the stimulator or the responder cell population with monoclonal anti-Ia antibodies leads to an inhibition of cell proliferation Journal of Immunology 127(6): 2438-2442
Steffelaar, J.W. 1979: The relativity of the concepts benign and malignant; an observation on the pleiomorphic adenoma (mixed tumor) of the salivary gland Nederlands Tijdschrift Voor Geneeskunde 123(52): 2209-2212
Gupta, S.C.; Mediratta, N.K. 1980: Chondroid syringoma: benign mixed tumour of skin of salivary gland type Indian Journal of Pathology and Microbiology 23(2): 143-146
Laugier, P.; Hunziker, N.; Laut, J.; Orusco, M.; Osmos, L. 1975: Reticulohistiocytosis of benign evolution (Hashimoto-Pritzker type). Electron microscopy study Annales de Dermatologie et de Syphiligraphie 102(1): 21-31
Ladjević, I.Likić.; Terzić, M.; Ladjević, N.; Dotlić, J.; Pilić, I.; Bila, J.; Knezević, N.; Milenković, S.; Maricić, S.; Arsenović, N.; Brndusić, N.; Nikolić, B. 2012: Introduction of new Tumor Marker Age Score in clinical practice: Validity evaluation for differentiation benign from malignant adnexal masses Acta chirurgica Iugoslavica 59(3): 49-56
Sollima, S.; Milazzo, L.; Vassalini, P.; Antinori, S.; Galli, M. 2018: Recurrence of mixed cryoglobulinaemia vasculitis following influenza vaccination despite clearance of hepatitis C virus infection Clinical and Experimental Rheumatology 36 Suppl 111(2): 161-162
Visentini, M.; Pascolini, S.; Mitrevski, M.; Marrapodi, R.; Del Padre, M.; Todi, L.; Camponeschi, A.; Axiotis, E.; Carlesimo, M.; De Santis, A.; Fiorilli, M.; Casato, M. 2016: Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody Clinical and Experimental Rheumatology 34(3 Suppl 97: S28-S32
Sherrington, P.D.; Fisch, P.; Taylor, A.M.; Rabbitts, T.H. 1994: Clonal evolution of malignant and non-malignant T cells carrying t(14;14) and t(X;14) in patients with ataxia telangiectasia Oncogene 9(8): 2377-2381
Meyer, D.H.; Bachem, M.G.; Gressner, A.M. 1990: Modulation of hepatic lipocyte proteoglycan synthesis and proliferation by Kupffer cell-derived transforming growth factors type beta 1 and type alpha Biochemical and Biophysical Research Communications 171(3): 1122-1129